|
1
|
Li Y and Teng C: Angiopoietin-like
proteins 3, 4 and 8 regulating lipid metabolism and providing new
hope for metabolic syndrome. J Drug Target. 22:679–687.
2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ren G, Kim JY and Smas CM: Identification
of RIFL, a novel adipocyte-enriched insulin target gene with a role
in lipid metabolism. Am J Physiol Endocrinol Metab. 303:E334–E351.
2012.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Dong XY, Pang XW, Yu ST, Su YR, Wang HC,
Yin YH, Wang YD and Chen WF: Identification of genes differentially
expressed in human hepatocellular carcinoma by a modified
suppression subtractive hybridization method. Int J Cancer.
112:239–248. 2004.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Fu Z, Yao F, Abou-Samra AB and Zhang R:
Lipasin, thermoregulated in brown fat, is a novel but atypical
member of the angiopoietin-like protein family. Biochem Biophys Res
Commun. 430:1126–1131. 2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Yi P, Park JS and Melton DA: Betatrophin:
a hormone that controls pancreatic β cell proliferation. Cell.
153:747–758. 2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Quagliarini F, Wang Y, Kozlitina J,
Grishin NV, Hyde R, Boerwinkle E, Valenzuela DM, Murphy AJ, Cohen
JC and Hobbs HH: Atypical angiopoietin-like protein that regulates
ANGPTL3. Proc Natl Acad Sci USA. 109:19751–19756. 2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wang Y, Quagliarini F, Gusarova V, Gromada
J, Valenzuela DM, Cohen JC and Hobbs HH: Mice lacking ANGPTL8
(Betatrophin) manifest disrupted triglyceride metabolism without
impaired glucose homeostasis. Proc Natl Acad Sci USA.
110:16109–16114. 2013.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Hijmans BS, Grefhorst A, Oosterveer MH and
Groen AK: Zonation of glucose and fatty acid metabolism in the
liver Mechanism and metabolic consequences. Biochimie. 96:121–129.
2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
von Loeffelholz, Pfeiffer AFH, Lock JF,
Lieske S, Docke S, Murahovschi V, Kriebel J, de Las Heras Gala,
Grallert H, Rudovich N, et al: ANGPTL8 (Betatrophin) is expressed
in visceral adipose tissue and relates to human hepatic steatosis
in two independent clinical collectives. Horm Metab Res.
49:343–349. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Lee YH, Lee SG, Lee CJ, Kim SH, Song YM,
Yoon MR, Jeon BH, Lee JH, Lee BW, Kang ES, et al: Association
between betatrophin/ANGPTL8 and non-alcoholic fatty liver disease
Animal and human studies. Sci Rep. 6(24013)2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Mysore R, Liebisch G, Zhou Y, Olkkonen VM
and Nidhina Haridas PA: Angiopoietin-like 8 (Angptl8) controls
adipocyte lipolysis and phospholipid composition. Chem Phys Lipids.
207:246–252. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Vatner DF, Goedeke L, Camporez JG, Lyu K,
Nasiri AR, Zhang D, Bhanot S, Murray SF, Still CD, Gerhard GS, et
al: Angptl8 antisense oligonucleotide improves adipose lipid
metabolism and prevents diet-induced NAFLD and hepatic insulin
resistance in rodents. Diabetologia. 61:1435–1446. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yu YH and Zhu H: Chronological changes in
metabolism and functions of cultured adipocytes A hypothesis for
cell aging in mature adipocytes. Am J Physiol Endocrinol Metab.
286:E402–E410. 2004.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Siddiqa A, Ahmad J, Ali A, Paracha RZ,
Bibi Z and Aslam B: Structural characterization of ANGPTL8
(betatrophin) with its interacting partner lipoprotein lipase.
Comput Biol Chem. 61:210–220. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Tseng YH, Yeh YH, Chen WJ and Lin KH:
Emerging regulation and function of betatrophin. Int J Mol Sci.
15:23640–23657. 2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Haller JF, Mintah IJ, Shihanian LM, Stevis
P, Buckler D, Alexa-Braun CA, Kleiner S, Banfi S, Cohen JC, Hobbs
HH, et al: ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase
and plasma triglyceride clearance. J Lipid Res. 58:1166–1173.
2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Nidhina Haridas PA, Soronen J, Sadevirta
S, Mysore R, Quagliarini F, Pasternack A, Metso J, Perttila J,
Leivonen M, Smas CM, et al: Regulation of angiopoietin-like
proteins (ANGPTLs) 3 and 8 by insulin. J Clin Endocrinol Metab.
100:E1299–E1307. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kovrov O, Kristensen KK, Larsson E, Ploug
M and Olivecrona G: On the mechanism of angiopoietin-like protein 8
for control of lipoprotein lipase activity. J Lipid Res.
60:783–793. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Guo T, Yin RX, Wu J, Lin QZ, Shi GY, Shen
SW, Sun JQ, Li H, Lin WX and Yan DZ: Association of the
angiopoietin-like protein 8 rs2278426 polymorphism and several
environmental factors with serum lipid levels. Mol Med Rep.
12:3285–3296. 2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Liu J, Yagi K, Nohara A, Chujo D, Ohbatake
A, Fujimoto A, Miyamoto Y, Kobayashi J and Yamagishi M: High
frequency of type 2 diabetes and impaired glucose tolerance in
Japanese subjects with the angiopoietin-like protein 8 R59W
variant. J Clin Lipidol. 12:331–337. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Espes D, Lau J and Carlsson PO: Increased
circulating levels of betatrophin in individuals with long-standing
type 1 diabetes. Diabetologia. 57:50–53. 2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Hu H, Sun W, Yu S, Hong X, Qian W, Tang B,
Wang D, Yang L, Wang J, Mao C, et al: Increased circulating levels
of betatrophin in newly diagnosed type 2 diabetic patients.
Diabetes Care. 37:2718–2722. 2014.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ebert T, Kralisch S, Wurst U, Lössner U,
Kratzsch J, Blüher M, Stumvoll M, Tönjes A and Fasshauer M:
Betatrophin levels are increased in women with gestational diabetes
mellitus compared to healthy pregnant controls. Eur J Endocrinol.
173:1–7. 2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Gusarova V, Alexa CA, Na E, Stevis PE, Xin
Y, Bonner-Weir S, Cohen JC, Hobbs HH, Murphy AJ, Yancopoulos GD and
Gromada J: ANGPTL8/betatrophin does not control pancreatic beta
cell expansion. Cell. 159:691–696. 2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Yi P, Park JS and Melton DA: Retraction
notice to Betatrophin A hormone that controls pancreatic β cell
proliferation. Cell. 168(326)2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Fenzl A, Itariu BK, Kosi L,
Fritzer-Szekeres M, Kautzky-Willer A, Stulnig TM and Kiefer FW:
Circulating betatrophin correlates with atherogenic lipid profiles
but not with glucose and insulin levels in insulin-resistant
individuals. Diabetologia. 57:1204–1208. 2014.PubMed/NCBI View Article : Google Scholar
|
